Reported 9 days ago
Moderna and Novavax shares fell sharply following reports that President-elect Donald Trump plans to nominate Robert F. Kennedy Jr., an anti-vaccine activist, to head the Department of Health and Human Services. Moderna's stock dipped over 5% and Novavax's over 7%, with their values down more than 30% in the last month. Trump's confirmation of the nomination and comments on allowing Kennedy to take a bold approach to healthcare have fueled investor concerns over the vaccine industry.
Source: YAHOO